- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular pathogenic pathways in extranodal NK/T cell lymphoma
Authors
Keywords
Extranodal NK/T cell lymphoma, Molecular pathogenesis, Hallmarks of cancer
Journal
Journal of Hematology & Oncology
Volume 12, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-04-02
DOI
10.1186/s13045-019-0716-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Programmed death-1 ligands PD-L1 and PD-L2 show distinctive and restricted patterns of expression in lymphoma subtypes
- (2018) Poonam K. Panjwani et al. HUMAN PATHOLOGY
- The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation
- (2018) Sanjay de Mel et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma
- (2018) Xin Li et al. Journal of Hematology & Oncology
- Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphoma
- (2018) M. -L. Nairismägi et al. LEUKEMIA
- Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK/T cell lymphoma
- (2018) Haijun Wen et al. NATURE MEDICINE
- Novel Immunotherapy Options for Extranodal NK/T-Cell Lymphoma
- (2018) Boyu Hu et al. Frontiers in Oncology
- Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
- (2018) Tammy Linlin Song et al. BLOOD
- Frequent Mutations in Natural Killer/T Cell Lymphoma
- (2018) Yanjie Zhang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Emerging roles of Myc in stem cell biology and novel tumor therapies
- (2018) Go J. Yoshida JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- LEE011 and ruxolitinib: a synergistic drug combination for natural killer/T-cell lymphoma (NKTCL)
- (2018) Yan Ting Hee et al. Oncotarget
- MiRNA-155 regulates lymphangiogenesis in natural killer/T-cell lymphoma by targeting BRG1
- (2018) Yu Chang et al. CANCER BIOLOGY & THERAPY
- Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes
- (2017) Siok-Bian Ng et al. HAEMATOLOGICA
- Introduction to checkpoint inhibitors and cancer immunotherapy
- (2017) Arlene H. Sharpe IMMUNOLOGICAL REVIEWS
- Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway
- (2017) Xianxian Sui et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment
- (2017) Go J. Yoshida Journal of Hematology & Oncology
- RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC
- (2017) V Selvarajan et al. LEUKEMIA
- CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
- (2017) Marian L. Burr et al. NATURE
- Whole transcriptome analysis reveals dysregulated oncogenic lncRNAs in natural killer/T-cell lymphoma and establishes MIR155HG as a target of PRDM1
- (2017) Esra Baytak et al. TUMOR BIOLOGY
- Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes
- (2017) Siok-Bian Ng et al. HAEMATOLOGICA
- Overexpression of MYC and BCL2 Predicts Poor Prognosis in Patients with Extranodal NK/T-cell Lymphoma, Nasal Type
- (2017) Jing-hua Wang et al. Journal of Cancer
- Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK/T-cell lymphoma, nasal type
- (2016) Jae-Cheol Jo et al. ANNALS OF HEMATOLOGY
- Histone deacetylase (HDAC) inhibitors when combined with a proteasome inhibitor are safe and effective in patients with extranodal natural killer/T-cell lymphoma (ENKTL)
- (2016) D. Tan et al. ANNALS OF ONCOLOGY
- EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphoma
- (2016) Junli Yan et al. BLOOD
- FrequentBCORaberrations in extranodal NK/T-Cell lymphoma, nasal type
- (2016) Akito Dobashi et al. GENES CHROMOSOMES & CANCER
- Hypermethylation of PRDM1/Blimp-1 promoter in extranodal NK/T-cell lymphoma, nasal type: an evidence of predominant role in its downregulation
- (2016) Zhang Zhang et al. HEMATOLOGICAL ONCOLOGY
- Antigen processing and immune regulation in the response to tumours
- (2016) Emma Reeves et al. IMMUNOLOGY
- Therapeutic options in peripheral T cell lymphoma
- (2016) Yaping Zhang et al. Journal of Hematology & Oncology
- PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma
- (2016) Xi-wen Bi et al. Journal of Hematology & Oncology
- Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study
- (2016) Zheng Li et al. LANCET ONCOLOGY
- Predictive biomarkers for checkpoint inhibitor-based immunotherapy
- (2016) Geoffrey T Gibney et al. LANCET ONCOLOGY
- Multifunctional role of the transcription factor Blimp-1 in coordinating plasma cell differentiation
- (2016) Martina Minnich et al. NATURE IMMUNOLOGY
- Targeting CD38 in Refractory Extranodal Natural Killer Cell–T-Cell Lymphoma
- (2016) Parameswaran Hari et al. NEW ENGLAND JOURNAL OF MEDICINE
- OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumors
- (2016) L A Jung et al. ONCOGENE
- Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis
- (2016) Wook Youn Kim et al. VIRCHOWS ARCHIV
- Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells
- (2016) Maryam Abbaspour Babaei et al. Drug Design Development and Therapy
- Notch signaling: its roles and therapeutic potential in hematological malignancies
- (2016) Yisu Gu et al. Oncotarget
- CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK/T cell lymphoma, nasal type
- (2015) Liang Wang et al. ANNALS OF HEMATOLOGY
- Epstein–Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin
- (2015) S. J. Kim et al. ANNALS OF ONCOLOGY
- Receptor-type tyrosine-protein phosphatase directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma
- (2015) Y.-W. Chen et al. BLOOD
- Global Promoter Methylation Analysis Reveals Novel Candidate Tumor Suppressor Genes in Natural Killer Cell Lymphoma
- (2015) C. Kucuk et al. CLINICAL CANCER RESEARCH
- The role for autophagy in cancer
- (2015) Eileen White JOURNAL OF CLINICAL INVESTIGATION
- Metabolic reprogramming: the emerging concept and associated therapeutic strategies
- (2015) Go J. Yoshida JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Epstein–Barr virus-associated T/natural killer-cell lymphoproliferative disorder in children and young adults has similar molecular signature to extranodal nasal natural killer/T-cell lymphoma but shows distinctive stem cell-like phenotype
- (2015) Siok-Bian Ng et al. LEUKEMIA & LYMPHOMA
- Targeting the DNA Damage Response in Cancer
- (2015) Mark J. O’Connor MOLECULAR CELL
- Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma
- (2015) Lu Jiang et al. NATURE GENETICS
- Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells
- (2015) Can Küçük et al. Nature Communications
- Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type
- (2015) Seungbok Lee et al. Oncotarget
- Targeting Oncogenic Mutant p53 for Cancer Therapy
- (2015) Alejandro Parrales et al. Frontiers in Oncology
- Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
- (2014) G. L. Beatty et al. CLINICAL CANCER RESEARCH
- TAK1-ECSIT-TRAF6 Complex Plays a Key Role in the TLR4 Signal to Activate NF-κB
- (2014) Sae Mi Wi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- High-resolution genome-wide analysis identified recurrent genetic alterations in NK/T-cell lymphoma, nasal type, which are associated with disease progression
- (2014) Lin Sun et al. MEDICAL ONCOLOGY
- PCR array analysis of gene expression profiles in chronic active Epstein–Barr virus infection
- (2014) Masanao Murakami et al. MICROBES AND INFECTION
- Activated Janus Kinase 3 expression not by activating mutations identified in Natural Killer/T-cell lymphoma
- (2014) Ying Guo et al. PATHOLOGY INTERNATIONAL
- Current research on chronic active Epstein-Barr virus infection in Japan
- (2014) Shigeyoshi Fujiwara et al. PEDIATRICS INTERNATIONAL
- EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity
- (2013) J. Yan et al. BLOOD
- Diagnostic and Prognostic Value of Circulating miR-221 for Extranodal Natural Killer/T-Cell Lymphoma
- (2013) Hong-Qiang Guo et al. DISEASE MARKERS
- MicroRNA function in NK-cell biology
- (2013) Aimee M. Beaulieu et al. IMMUNOLOGICAL REVIEWS
- Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins
- (2013) Catherine M. Bollard et al. JOURNAL OF CLINICAL ONCOLOGY
- Plasma Viral MicroRNA Profiles Reveal Potential Biomarkers for Chronic Active Epstein–Barr Virus Infection
- (2013) Yoshihiko Kawano et al. JOURNAL OF INFECTIOUS DISEASES
- JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma
- (2013) A Bouchekioua et al. LEUKEMIA
- Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404)
- (2013) Kristen Ganjoo et al. LEUKEMIA & LYMPHOMA
- Rare occurrence ofJAK3mutations in natural killer cell neoplasms in Japan
- (2013) Hiroshi Kimura et al. LEUKEMIA & LYMPHOMA
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- MicroRNA regulation of natural killer cells
- (2013) Ryan P. Sullivan et al. Frontiers in Immunology
- HACE1 Is a Tumor Suppressor Gene Candidate in Natural Killer Cell Neoplasms
- (2012) Can Küçük et al. AMERICAN JOURNAL OF PATHOLOGY
- Lineage-specific growth inhibition of NK cell lines by FOXO3 in association with Akt activation status
- (2012) Kennosuke Karube et al. EXPERIMENTAL HEMATOLOGY
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- MicroRNA Profiling of Epstein-Barr Virus-Associated NK/T-Cell Lymphomas by Deep Sequencing
- (2012) Natalie Motsch et al. PLoS One
- Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma
- (2012) Ghee Chong Koo et al. Cancer Discovery
- Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma
- (2011) S.-B. Ng et al. BLOOD
- Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses
- (2011) K. Karube et al. BLOOD
- The potential role of Aurora kinase inhibitors in haematological malignancies
- (2011) Sherif S. Farag BRITISH JOURNAL OF HAEMATOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Epstein-Barr virus-mediated dysregulation of human microRNA expression
- (2011) Sirie Godshalk et al. CELL CYCLE
- The Beclin 1 network regulates autophagy and apoptosis
- (2011) R Kang et al. CELL DEATH AND DIFFERENTIATION
- MicroRNA-146a Downregulates NF B Activity via Targeting TRAF6 and Functions as a Tumor Suppressor Having Strong Prognostic Implications in NK/T Cell Lymphoma
- (2011) J. H. Paik et al. CLINICAL CANCER RESEARCH
- Extranodal NK/T-Cell Lymphoma: Toward the Identification of Clinical Molecular Targets
- (2011) Christian Schmitt et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- PRDM1 is a tumor suppressor gene in natural killer cell malignancies
- (2011) C. Kucuk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Beclin 1 expression: A predictor of prognosis in patients with extranodal natural killer T-cell lymphoma, nasal type
- (2010) Jia-Jia Huang et al. Autophagy
- Constitutive Canonical NF-κB Activation Cooperates with Disruption of BLIMP1 in the Pathogenesis of Activated B Cell-like Diffuse Large Cell Lymphoma
- (2010) Dinis Pedro Calado et al. CANCER CELL
- BLIMP1 Is a Tumor Suppressor Gene Frequently Disrupted in Activated B Cell-like Diffuse Large B Cell Lymphoma
- (2010) Jonathan Mandelbaum et al. CANCER CELL
- Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies
- (2010) Jon C Aster et al. JOURNAL OF PATHOLOGY
- Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling
- (2010) Siok-Bian Ng et al. JOURNAL OF PATHOLOGY
- Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro
- (2010) J Iqbal et al. LEUKEMIA
- Aurora kinase A is a target of Wnt/ -catenin involved in multiple myeloma disease progression
- (2009) J. Dutta-Simmons et al. BLOOD
- Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type
- (2009) Y. Huang et al. BLOOD
- Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia
- (2009) Y. Yamanaka et al. BLOOD
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases
- (2009) Xiaoyu Hu et al. IMMUNITY
- NF- B Activation Through the Alternative Pathway Correlates with Chemoresistance and Poor Survival in Extranodal NK/T-cell Lymphoma, Nasal Type
- (2009) X. Liu et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs
- (2009) Fernando Cruz-Guilloty et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies
- (2009) J Iqbal et al. LEUKEMIA
- STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma
- (2009) P Coppo et al. LEUKEMIA
- Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas
- (2009) Judit M. Jørgensen et al. LEUKEMIA & LYMPHOMA
- Epstein-Barr Virus in Lymphoproliferative Processes
- (2008) Siok-Bian Ng et al. ADVANCES IN ANATOMIC PATHOLOGY
- Role of platelet-derived growth factors in physiology and medicine
- (2008) J. Andrae et al. GENES & DEVELOPMENT
- Drug development of MET inhibitors: targeting oncogene addiction and expedience
- (2008) Paolo M. Comoglio et al. NATURE REVIEWS DRUG DISCOVERY
- Epstein–Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-κB pathway
- (2008) Graziana Gatto et al. NUCLEIC ACIDS RESEARCH
- Thrombospondin-1 (TSP-1) and Survivin (S) expression in non-Hogkin's lymphomas
- (2007) Semra Paydas et al. LEUKEMIA RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started